日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The validated French CFAbd-Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor

经验证的法国CFAbd评分显示，服用Elexacaftor/Tezacaftor/Ivacaftor的患者胃肠道症状负担较轻。

期刊:Journal of Pediatric Gastroenterology and Nutrition
影响因子:
doi:10.1002/jpn3.70244
Sermet-Gaudelus, Isabelle; Sadrieh, Pauline; Bonnel, Anne Sophie; Enaud, Raphael; Wizla, Nathalie; Languepin, Jeanne; Nangui, Ambre; Deelawon, Audrey; Rave, Johanna; Dabelow, Samira; Barucha, Anton; Zagoya, Carlos; Duckstein, Franziska; Mainz, Jochen Georg
发表日期：2026
文献求助 收藏

Cross-cultural adaptation and validation of the CFAbd-Score for gastrointestinal symptoms in patients with cystic fibrosis

囊性纤维化患者胃肠道症状CFAbd评分的跨文化适应性和验证

期刊:Jornal De Pediatria
影响因子:2.5
doi:10.1016/j.jped.2024.07.004
Infante, Flávia N S; Lomazi, Elizete A; Zagoya, Carlos; Duckstein, Franziska; Magro, Daniela O; Pessotto, Fernando; Ribeiro, Antônio F; Ribeiro, José D; Mainz, Jochen G
发表日期：2025
文献求助 收藏

Scoring Abdominal Symptoms in People with Cystic Fibrosis

对囊性纤维化患者的腹部症状进行评分

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm13061650
Tabori, Harold; Barucha, Anton; Zagoya, Carlos; Duckstein, Franziska; Dunay, Gabor A; Sadrieh, Pauline; Polte, Louise; Mainz, Jochen G
发表日期：2024
文献求助 收藏

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score

更正：Elexacaftor-Tezacaftor-Ivacaftor 联合治疗可减轻囊性纤维化患者的腹部症状——使用囊性纤维化特异性 CFAbd-Score 评分获得的早期结果

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1207356
Mainz, Jochen G; Zagoya, Carlos; Polte, Louise; Naehrlich, Lutz; Sasse, Lenny; Eickmeier, Olaf; Smaczny, Christina; Barucha, Anton; Bechinger, Lilith; Duckstein, Franziska; Kurzidim, Ludwik; Eschenhagen, Patience; Caley, Laura; Peckham, Daniel; Schwarz, Carsten
发表日期：2023
文献求助 收藏

Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire

使用新型 CFAbd-day2day 问卷评估 elexacaftor/tezacaftor/ivacaftor 新疗法开始时腹部症状的动态变化

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1167407
Mainz, Jochen G; Barucha, Anton; Huang, Pu; Bechinger, Lilith; Duckstein, Franziska; Polte, Louise; Sadrieh, Pauline; Nährlich, Lutz; Eickmeier, Olaf; Van Dullemen, Suzanne; Eschenhagen, Patience; Schwarz, Carsten; Lüth, Stefan; Zagoya, Carlos; Graepler-Mainka, Ute
发表日期：2023
文献求助 收藏

Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage

囊性纤维化患者和健康对照组在气道感染期间炎症介质和多重PCR的动态变化差异：通过鼻腔冲洗进行连续上呼吸道采样

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.947359
Erdmann, Nina; Schilling, Theresa; Hentschel, Julia; Lehmann, Thomas; von Bismarck, Philipp; Ankermann, Tobias; Duckstein, Franziska; Baier, Michael; Zagoya, Carlos; Mainz, Jochen G
炎症/感染
炎症
发表日期：2022
文献求助 收藏

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score

Elexacaftor-Tezacaftor-Ivacaftor 联合治疗可减轻囊性纤维化患者的腹部症状——基于囊性纤维化特异性 CFAbd 评分的早期结果

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.877118
Mainz, Jochen G; Zagoya, Carlos; Polte, Louise; Naehrlich, Lutz; Sasse, Lenny; Eickmeier, Olaf; Smaczny, Christina; Barucha, Anton; Bechinger, Lilith; Duckstein, Franziska; Kurzidim, Ludwik; Eschenhagen, Patience; Caley, Laura; Peckham, Daniel; Schwarz, Carsten
发表日期：2022
文献求助 收藏

Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid

Ivacaftor 可减少 G551D 突变囊性纤维化患者上呼吸道内壁液中的炎症介质：连续非侵入性家庭上呼吸道内壁液收集

期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2021.642180
Jochen G Mainz, Christin Arnold, Kara Wittstock, Uta-Christina Hipler, Thomas Lehmann, Carlos Zagoya, Franziska Duckstein, Helmut Ellemunter, Julia Hentschel
免疫
发表日期：2021
文献求助 收藏

Would it have happened without Christmas? Thoracic emphysema and allergic bronchopulmonary aspergillosis in a juvenile cystic fibrosis patient with the G551D mutation receiving ivacaftor

如果没有圣诞节，这一切还会发生吗？一名患有G551D突变的青少年囊性纤维化患者接受伊伐卡托治疗后，出现胸廓气肿和过敏性支气管肺曲霉病。

期刊:Erj Open Research
影响因子:4
doi:10.1183/23120541.00758-2020
Mainz, Jochen G; Erdmann, Nina; Duckstein, Franziska; Zagoya, Carlos
发表日期：2021
文献求助 收藏

Flavonoids as Putative Inducers of the Transcription Factors Nrf2, FoxO, and PPAR γ

黄酮类化合物可能是转录因子 Nrf2、FoxO 和 PPARγ 的诱导剂

期刊:Oxidative Medicine and Cellular Longevity
影响因子:
doi:10.1155/2017/4397340
Kathrin Pallauf, Nils Duckstein, Mario Hasler, Lars-Oliver Klotz, Gerald Rimbach
信号转导
发表日期：2017
文献求助 收藏